24367-70-2Relevant academic research and scientific papers
11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid β in Alzheimer's disease
Serdons,Verduyckt,Vanderghinste,Borghgraef,Cleynhens,Van Leuven,Kung,Bormans,Verbruggen
experimental part, p. 1415 - 1426 (2009/07/04)
Pittsburgh Compound-B (PIB) is currently being evaluated clinically for in vivo visualization of amyloid plaques in patients with Alzheimer's disease (AD). We have synthesized three structural isomers of 6-hydroxy-2-(4′-aminophenyl)-1,3-benzothiazole, per
Antitumor benzothiazoles. 8.1 Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4- aminophenyl)-benzothiazoles
Kashiyama, Eiji,Hutchinson, Ian,Chua, Mei-Sze,Stinson, Sherman F.,Phillips, Lawrence R.,Kaur, Gurmeet,Sausville, Edward A.,Bradshaw, Tracey D.,Westwell, Andrew D.,Stevens, Malcolm F. G.
, p. 4172 - 4184 (2007/10/03)
2-(4-Aminophenyl)benzothiazoles 1 and their N-acetylated forms have been converted to C and N-hydroxylated derivatives to investigate the role of metabolic oxidation in the mode of action of this series of compounds. 2-(4- Amino-3-methylphenyl)benzothiazole (1a, DF 203, NSC 674495) is a novel and potent antitumor agent with selective growth inhibitory properties against human cancer cell lines. Very low IC50 values (14C]1a derived radioactivity was observed in the sensitive MCF-7 cell line but not in the insensitive MDA-MB-435 cell line. The mechanism of growth inhibition by 1a, which is unknown, may be dependent on the differential metabolism of the drug to an activated form by sensitive cell lines only and its covalent binding to an intracellular protein. However, the 6-hydroxy derivative 6c is not the 'active' metabolite since, like all other C- and N-hydroxylated benzothiazoles examined in this study, it is devoid of antitumor properties in vitro.
